Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001104659-21-125416
Filing Date
2021-10-12
Accepted
2021-10-12 17:19:32
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC14D9C tm2129361d4_sc14d9.htm SC14D9C 26721
2 EXHIBIT 99.1 tm2129361d4_ex99-1.htm EX-99.1 19436
3 GRAPHIC image_001.jpg GRAPHIC 2087
  Complete submission text file 0001104659-21-125416.txt   50937
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filed by) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Subject) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-88106 | Film No.: 211319394
SIC: 2834 Pharmaceutical Preparations